Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Mechanistic role of ns2 protein in evasion of innate immune response by alphaviruses

Award Number: R01AI133159
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/16/2017
PERIOD OF PERFORMANCE END DATE: 05/31/2023

Group Awards By:

View Award Description

Mechanistic role of ns2 protein in evasion of innate immune response by alphaviruses - Alphaviruses are an important group of human and animal pathogens that are widely distributed on all continents. Until recently, the importance of the Old World alphaviruses in global human health was strongly underestimated. However, recent outbreaks of chikungunya virus (CHIKV) in India, Italy, East Africa's coastal islands and most recently on the Caribbean islands, South and Central America, Oceania have highlighted the risk posed by this virus. Our previous studies have unambiguously demonstrated that the Old World alphaviruses employ their nonstructural protein nsP2 to re-direct the cellular transcription coupled repair pathway for degradation of the catalytic subunit of the DNA- dependent RNA polymerase II, RPB1, and thus, to completely inhibit cellular transcription. Within a few hours post infection, virus-induced transcriptional shutoff makes the cells incapable of initiating an antiviral response and leads to development of cytopathic effect. Thus, the Old World alphavirus nsP2 is the major determinant of pathogenesis at the molecular and cellular levels. We have also demonstrated that the transcription inhibitory functions of nsP2 are determined not by its proteolytic activity, but by the ability of this protein to function as a helicase, and by its S-adenosyl-L- methionine-dependent RNA methyltransferase-like (SAM-like) domain. Two specific aims of the proposed research plan are focused on i) mechanistic understanding of the nsP2 helicase domain function in stalling cellular DNA-dependent RNA polymerase II and ii) on identification of cellular proteins that interact with the SAM-like domain of nsP2. We will also define the mechanistic role of the interactions of the latter domain in transcription inhibition. In our preliminary studies, we have developed a set of CHIKV variants with mutated nsP2, which are incapable of interfering with development of the innate immune response to CHIKV replication. These irreversible mutations had no detectable effect on the rates of CHIKV replication in cells defective in type I IFN signaling, but are cleared from IFN-competent cells without development of cytopathic effect. Therefore, in the third specific aim, we intend to assess the potential of these nsP2 mutants to improve the safety of the currently available experimental vaccine CHIKV 181/25.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$222 )
2024	2021	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Allergy and Infectious Diseases Research	000	5	4/9/2024	NON-COMPETING CONTINUATION	-$222
														Subtotal = -$222

Issue Date FY: 2021 ( Subtotal = $603,624 )
2021	2021	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Allergy and Infectious Diseases Research	000	5	5/25/2021	NON-COMPETING CONTINUATION	$603,624
														Subtotal = $603,624

Issue Date FY: 2020 ( Subtotal = $614,019 )
2020	2020	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Allergy and Infectious Diseases Research	000	4	5/15/2020	NON-COMPETING CONTINUATION	$614,019
														Subtotal = $614,019

Issue Date FY: 2019 ( Subtotal = $597,093 )
2019	2019	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Allergy and Infectious Diseases Research	000	3	5/14/2019	NON-COMPETING CONTINUATION	$597,093
														Subtotal = $597,093

Issue Date FY: 2018 ( Subtotal = $629,763 )
2018	2018	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Allergy and Infectious Diseases Research	000	2	5/16/2018	NON-COMPETING CONTINUATION	$629,763
														Subtotal = $629,763

Issue Date FY: 2017 ( Subtotal = $589,668 )
2017	2017	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Allergy and Infectious Diseases Research	000	1	6/16/2017	NEW	$589,668
														Subtotal = $589,668

Grand Total All Awards = $3,033,945

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Mechanistic role of ns2 protein in evasion of innate immune response by alphaviruses

Award Number: R01AI133159

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/16/2017

PERIOD OF PERFORMANCE END DATE: 05/31/2023

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer